vs
Biglari Holdings Inc.（BH）与PUMA BIOTECHNOLOGY, INC.（PBYI）财务数据对比。点击上方公司名可切换其他公司
Biglari Holdings Inc.的季度营收约是PUMA BIOTECHNOLOGY, INC.的1.3倍（$99.9M vs $75.5M），PUMA BIOTECHNOLOGY, INC.同比增速更快（27.7% vs 9.6%），PUMA BIOTECHNOLOGY, INC.自由现金流更多（$14.4M vs $6.4M），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs 5.7%）
Biglari控股是一家总部位于美国得克萨斯州圣安东尼奥的控股公司，由企业家萨达尔·比格拉里创立。旗下业务涵盖餐饮、出版、保险、石油能源多个领域，旗下子品牌包括Steak 'n Shake、《马克西姆》杂志、第一卫士保险、南先锋保险、南方石油、阿布拉克萨斯石油等。
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
BH vs PBYI — 直观对比
营收规模更大
BH
是对方的1.3倍
$75.5M
营收增速更快
PBYI
高出18.1%
9.6%
自由现金流更多
PBYI
多$8.0M
$6.4M
两年增速更快
PBYI
近两年复合增速
5.7%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $99.9M | $75.5M |
| 净利润 | $-49.9M | — |
| 毛利率 | 58.3% | 69.3% |
| 营业利润率 | -64.1% | 22.7% |
| 净利率 | -49.9% | — |
| 营收同比 | 9.6% | 27.7% |
| 净利润同比 | -385.3% | — |
| 每股收益（稀释后） | — | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BHPBYI
| Q4 25 | $99.9M | $75.5M | ||
| Q3 25 | $99.7M | $54.5M | ||
| Q2 25 | $100.6M | $52.4M | ||
| Q1 25 | $95.0M | $46.0M | ||
| Q4 24 | $91.1M | $59.1M | ||
| Q3 24 | $90.4M | $80.5M | ||
| Q2 24 | $91.1M | $47.1M | ||
| Q1 24 | $89.5M | $43.8M |
净利润BHPBYI
| Q4 25 | $-49.9M | — | ||
| Q3 25 | $-5.3M | $8.8M | ||
| Q2 25 | $50.9M | $5.9M | ||
| Q1 25 | $-33.3M | $3.0M | ||
| Q4 24 | $-10.3M | — | ||
| Q3 24 | $32.1M | $20.3M | ||
| Q2 24 | $-48.2M | $-4.5M | ||
| Q1 24 | $22.6M | $-4.8M |
毛利率BHPBYI
| Q4 25 | 58.3% | 69.3% | ||
| Q3 25 | 58.1% | 77.7% | ||
| Q2 25 | 60.2% | 76.5% | ||
| Q1 25 | 60.3% | 77.1% | ||
| Q4 24 | 60.6% | 76.4% | ||
| Q3 24 | 59.9% | 63.9% | ||
| Q2 24 | 59.5% | 77.4% | ||
| Q1 24 | 61.5% | 75.5% |
营业利润率BHPBYI
| Q4 25 | -64.1% | 22.7% | ||
| Q3 25 | -7.6% | 17.6% | ||
| Q2 25 | 64.7% | 12.7% | ||
| Q1 25 | -43.3% | 8.7% | ||
| Q4 24 | -19.7% | 22.6% | ||
| Q3 24 | 47.9% | 27.4% | ||
| Q2 24 | -69.0% | -4.6% | ||
| Q1 24 | 32.9% | -5.3% |
净利率BHPBYI
| Q4 25 | -49.9% | — | ||
| Q3 25 | -5.3% | 16.2% | ||
| Q2 25 | 50.6% | 11.2% | ||
| Q1 25 | -35.0% | 6.5% | ||
| Q4 24 | -11.3% | — | ||
| Q3 24 | 35.5% | 25.2% | ||
| Q2 24 | -52.9% | -9.6% | ||
| Q1 24 | 25.2% | -11.0% |
每股收益（稀释后）BHPBYI
| Q4 25 | — | $0.26 | ||
| Q3 25 | — | $0.17 | ||
| Q2 25 | — | $0.12 | ||
| Q1 25 | — | $0.06 | ||
| Q4 24 | — | $0.40 | ||
| Q3 24 | — | $0.41 | ||
| Q2 24 | — | $-0.09 | ||
| Q1 24 | — | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $268.8M | $97.5M |
| 总债务越低越好 | — | $22.7M |
| 股东权益账面价值 | $523.4M | $130.3M |
| 总资产 | $1.0B | $216.3M |
| 负债/权益比越低杠杆越低 | — | 0.17× |
8季度趋势，按日历期对齐
现金及短期投资BHPBYI
| Q4 25 | $268.8M | $97.5M | ||
| Q3 25 | $272.5M | $94.4M | ||
| Q2 25 | $32.8M | $96.0M | ||
| Q1 25 | $28.7M | $93.2M | ||
| Q4 24 | $30.7M | $101.0M | ||
| Q3 24 | $29.9M | $96.7M | ||
| Q2 24 | $26.9M | $96.8M | ||
| Q1 24 | $34.5M | $107.2M |
总债务BHPBYI
| Q4 25 | — | $22.7M | ||
| Q3 25 | — | $34.0M | ||
| Q2 25 | — | $45.3M | ||
| Q1 25 | — | $56.7M | ||
| Q4 24 | — | $68.0M | ||
| Q3 24 | — | $79.3M | ||
| Q2 24 | — | $90.7M | ||
| Q1 24 | — | $102.0M |
股东权益BHPBYI
| Q4 25 | $523.4M | $130.3M | ||
| Q3 25 | $580.3M | $115.3M | ||
| Q2 25 | $589.3M | $104.7M | ||
| Q1 25 | $539.8M | $97.1M | ||
| Q4 24 | $573.0M | $92.1M | ||
| Q3 24 | $601.8M | $71.1M | ||
| Q2 24 | $569.2M | $48.5M | ||
| Q1 24 | $618.6M | $51.0M |
总资产BHPBYI
| Q4 25 | $1.0B | $216.3M | ||
| Q3 25 | $1.1B | $202.9M | ||
| Q2 25 | $863.6M | $194.9M | ||
| Q1 25 | $829.1M | $196.2M | ||
| Q4 24 | $866.1M | $213.3M | ||
| Q3 24 | $865.1M | $220.7M | ||
| Q2 24 | $809.1M | $205.0M | ||
| Q1 24 | $885.3M | $214.1M |
负债/权益比BHPBYI
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.30× | ||
| Q2 25 | — | 0.43× | ||
| Q1 25 | — | 0.58× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 1.12× | ||
| Q2 24 | — | 1.87× | ||
| Q1 24 | — | 2.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $17.8M | $14.4M |
| 自由现金流经营现金流 - 资本支出 | $6.4M | $14.4M |
| 自由现金流率自由现金流/营收 | 6.4% | 19.1% |
| 资本支出强度资本支出/营收 | 11.4% | 0.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $76.6M | $41.7M |
8季度趋势，按日历期对齐
经营现金流BHPBYI
| Q4 25 | $17.8M | $14.4M | ||
| Q3 25 | $31.2M | $9.7M | ||
| Q2 25 | $42.1M | $14.1M | ||
| Q1 25 | $15.8M | $3.6M | ||
| Q4 24 | $18.0M | $15.6M | ||
| Q3 24 | $10.8M | $11.0M | ||
| Q2 24 | $1.8M | $1.0M | ||
| Q1 24 | $19.1M | $11.2M |
自由现金流BHPBYI
| Q4 25 | $6.4M | $14.4M | ||
| Q3 25 | $22.3M | $9.7M | ||
| Q2 25 | $39.4M | $14.1M | ||
| Q1 25 | $8.5M | $3.6M | ||
| Q4 24 | $10.9M | $15.6M | ||
| Q3 24 | $3.7M | $11.0M | ||
| Q2 24 | $-10.0M | $1.0M | ||
| Q1 24 | $14.5M | — |
自由现金流率BHPBYI
| Q4 25 | 6.4% | 19.1% | ||
| Q3 25 | 22.4% | 17.7% | ||
| Q2 25 | 39.2% | 26.8% | ||
| Q1 25 | 8.9% | 7.7% | ||
| Q4 24 | 12.0% | 26.4% | ||
| Q3 24 | 4.1% | 13.7% | ||
| Q2 24 | -11.0% | 2.1% | ||
| Q1 24 | 16.2% | — |
资本支出强度BHPBYI
| Q4 25 | 11.4% | 0.0% | ||
| Q3 25 | 9.0% | 0.0% | ||
| Q2 25 | 2.7% | 0.0% | ||
| Q1 25 | 7.7% | 0.1% | ||
| Q4 24 | 7.8% | 0.0% | ||
| Q3 24 | 7.8% | 0.0% | ||
| Q2 24 | 13.0% | 0.0% | ||
| Q1 24 | 5.1% | 0.0% |
现金转化率BHPBYI
| Q4 25 | — | — | ||
| Q3 25 | — | 1.10× | ||
| Q2 25 | 0.83× | 2.41× | ||
| Q1 25 | — | 1.21× | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.33× | 0.54× | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.85× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BH
| Products | $45.9M | 46% |
| Franchisor | $20.5M | 21% |
| Insurance Operations | $19.1M | 19% |
| Oil And Gas Segment | $5.4M | 5% |
| Royalty | $4.1M | 4% |
| Abraxas Petroleum | $2.7M | 3% |
| Other | $2.2M | 2% |
PBYI
暂无分部数据
